The chairman also said that thier ability to participate has not been impacted and have not purchased from Nab since 2017. Let's wait to see at H1 and further updates if these assurances change. CLH is highly leveraged and at it's apparent 50% covenant max (afr). I think that in itself will restrict it, despite the effective agency deal it has with Balbec Capital.
Reading between the lines, CCP's access to capital is looking like a big competitive advantage right now, on top of the (un)fortunate reputational hits being felt by competitors. Looks like CCP might be able to bid lower prices based on it's more ethical practices track record and lack of competitor capacity over coming months.
CCP Price at posting:
$29.71 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)